查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1478024

热原测试市场：依产品类型、最终用户、地区 - 全球产业分析、规模、占有率、成长、趋势、预测，2024-2031 年

Pyrogen Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 444 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究最近发布了对全球热原测试市场的深入分析，全面概述了关键市场动态、成长动力/课题和新兴趋势。该报告提供了预测 2024 年至 2031 年市场成长轨蹟的独家数据和统计数据，并提供了有关热原测试市场的宝贵见解。

全球热原测试市场预计到2024年将达到20.4亿美元，并在未来10年以12.2%的复合年增长率成长。预测表明，到2031年，市场收入将飙升至45.6亿美元，表明市场将出现显着且积极的扩张。

重要见解

  • 热原测试市场规模（2024 年）：20.4 亿美元
  • 市场预测金额（2031年）：45.6亿美元
  • 全球市场成长率（2024-2031）：复合年增长率12.2%

热原测试市场 - 报告范围：

热原测试是製药和医疗器材製造的重要方面，透过检测热原污染来确保产品的安全性和有效性。本报告探讨了推动热原测试在全球范围内采用的各种应用和技术进步。

有几个因素正在推动热原测试市场的成长。严格的监管要求、对病人安全的日益关注以及热原污染事件的增加正在推动市场扩张。此外，测试技术的进步，例如体外方法和自动化系统的采用，正在提高测试的准确性和效率，进一步刺激市场成长。

市场成长动力：

热原测试市场受益于要求热原污染测试的製药和医疗器材製造的严格监管环境。此外，製造商越来越认识到热原测试对于确保产品安全和合规性的重要性，这正在推动市场需求。此外，测试方法的技术进步（例如快速自动化测试系统的引入）正在透过简化测试流程和缩短交付时间来推动市场成长。

市场限制因素：

儘管预计会出现成长，但热原测试市场也存在课题。与测试程序和设备相关的高成本是中小企业进入市场的障碍。此外，测试方法的复杂性和对专业知识的需求限制了采用率，特别是在新兴国家。此外，对某些测试方法的准确性和可靠性的担忧可能会阻碍市场成长，因此需要继续进行研究和开发来应对这些课题。

市场机会：

热原测试市场存在巨大的创新和扩展机会。旨在改善检测方法、提高灵敏度和特异性、降低检测成本的持续研发是打开新市场的关键。此外，将机器人和人工智慧等先进技术整合到检测系统中可以进一步简化流程并提高效率，从而推动市场成长。

本报告解决的关键问题

  • 推动热原测试市场成长的关键因素是什么？
  • 哪些产业和应用程式正在推动热原测试的需求？
  • 技术进步如何改变热原测试市场的竞争格局？
  • 谁是全球热原测试市场的主要参与者？
  • 全球热原测试市场的新兴趋势和未来前景预测是什么？

竞争资讯与经营策略：

在热原测试设备领域，製造商策略性地将重点放在监管批准、产品发布和收购上，以提高其在市场上的影响力。一项值得注意的进展是，Eurofins 于 2022 年 1 月推出了 PFAS Exposure(TM)，这是第一个测量 PFAS 水平的家庭测试。同样，2021 年 4 月，Associates of Cape Cod, Inc. (ACC) 推出了 PyroSmart NextGen□，这是一种用于细菌内毒素检测 (BET) 的创新重组鲎试剂。Lonza 于 2020 年 10 月推出的 Pyrocell 单核细胞活化测试系统提供了全面的体外热原测试解决方案，将 Sankin 的优化 MAT 试剂与 Lonza 的介质和配件相结合。持久性市场研究正在密切追踪热原测试领域的此类市场发展，并在综合报告中提供详细的见解。

主要公司简介

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • MAT-BioTech
  • Promega Corporation
  • GenScript
  • Associates of Cape Cod, Inc.
  • BIOMERIEUX SA
  • Ella A/S
  • Hycult Biotech Inc.
  • Eurofins Biolab Srl
  • Solvias AG
  • Wickham Laboratories Ltd.
  • Sotera Health (Nelson Laboratories, LLC)
  • Charles River Laboratories
  • Creative Biolabs
  • Sanquin Reagents B.V.
  • Fujifilm Wako Pure Chemical Corporation
  • MAT Research
  • Xiamen Bioendo Technology Co. Ltd.
  • Microcoat Biotechnologie GmbH
  • PerkinElmer Inc.
  • Orchid Scientific & Innovative Pvt Ltd.

热原测试市场细分

热原测试市场：依产品/服务分类

  • 机器

数位温度计设备

全自动内毒素检测装置

便携式内毒素检测设备

□标仪

  • 测试套件/试剂

重组因子C测定方法

鲎变形细胞裂解物 (LAL) 测试

  • 试色
  • 浊度测量
  • 凝胶凝块试验

兔热原试验

单核细胞活性测定方法

  • 消耗品
  • 服务

内毒素检测服务

单核细胞活化测试服务

依来源划分的热原测试市场

  • 基于体外的热原测试

全血单核细胞

基于週边血单核细胞 (PBMC) 的单核细胞

基于细胞系的单核细胞

  • 动物热原测试

重组因子 (rFC)

细菌内毒素（BET）

兔热原试验

依应用划分的热原测试市场

  • 注射疗法
  • 疫苗接种
  • 口服药物
  • 生物製剂
  • 植入式医疗器械
  • 透析液
  • 有毒/免疫调节药物
  • 血液製品

热原测试市场：依最终用户分类

  • 製药公司
  • 生物技术公司
  • 医疗器材公司
  • 诊断实验室
  • 临床研究组织（CRO）
  • 临床製造组织 (CMO)

热原测试市场：依地区

  • 北美热原测试市场
  • 拉丁美洲热原测试市场
  • 欧洲热原测试市场
  • 南亚热原测试市场
  • 东亚热原测试市场
  • 大洋洲热原测试市场
  • 中东和非洲热原测试市场

目录

第一章内容提要

第二章市场概况

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含/排除

第 3 章主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第 4 章关键成功因素

  • 临床试验分析
  • 未满足的需求
  • 监管场景
  • 热原和内毒素的检测方法
  • 预计进行的测试数量

第五章市场背景

  • 宏观经济因素
  • 预测变量 - 相关性和影响
  • 市场动态

第 6 章 COVID19 危机分析

  • 目前的 COVID-19 统计数据和未来潜在的影响
  • 目前经济预测 与 2008 年相比的经济分析
  • COVID-19 对医疗保健产业的影响
  • COVID-19 对全球热原测试市场的影响

第七章全球热原测试市场需求及数量分析

  • 2019-2023 年历史市场量分析
  • 2024-2031 年当前和未来市场量预测
    • 同比增长趋势分析

第八章全球热原测试市场-价格分析

  • 全球平均价格分析基准
  • 价格分析：依地区
  • 定价假设

第九章全球热原测试市场需求分析

  • 2019-2023年历史市值分析
  • 当前和未来市场价值预测，2024-2031
    • 同比增长趋势分析
    • 绝对量机会分析

第10章全球热原测试市场分析：依产品和服务

  • 简介/主要发现
  • 过去的市场规模和数量分析：依产品/服务，2019-2023
  • 目前和未来的市场规模和数量分析与预测：依产品和服务划分，2024-2031 年
    • 机器
    • 测试套件/试剂
    • 消耗品
    • 服务
  • 市场吸引力分析：依产品/服务

第十一章全球热原测试市场分析：依来源分类

  • 简介/主要发现
  • 过去的市场规模分析（依来源地），2019-2023
  • 当前和未来的市场规模分析和预测：依来源划分，2024-2031 年
    • 基于体外
    • 基于动物
  • 市场吸引力分析：依来源划分

第十二章全球热原测试市场分析：依应用分类

  • 简介/主要发现
  • 历史市场规模分析：依应用分类，2019-2023
  • 目前和未来市场规模的分析和预测：依应用分类，2024-2031
    • 注射
    • 疫苗接种
    • 口服药物
    • 生物製品
    • 植入式医疗器械
    • 透析液
    • 有毒/免疫调节药物
    • 血液衍生产品
  • 市场吸引力分析：依应用

第 13 章全球热原测试市场分析：依最终用户分类

  • 简介/主要发现
  • 历史市场规模分析：依最终用户划分，2019-2023
  • 当前和未来市场规模的分析和预测：依最终用户划分，2024-2031 年
    • 製药公司
    • 生物技术公司
    • 医疗器材公司
    • 诊断实验室
    • 临床研究组织（CRO）
    • 临床製造组织 (CMO)
  • 市场吸引力分析：依最终用户

第14章全球热原测试市场分析：依地区

  • 介绍
  • 历史市场规模与数量分析：依地区划分，2019-2023
  • 当前市场规模和数量分析及预测：依地区划分，2024-2031 年
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东和非洲 (MEA)
  • 市场吸引力分析：依地区

第十五章北美热原测试市场分析

第十六章拉丁美洲热原测试市场分析

第十七章欧洲热原测试市场分析

第十八章南亚热原测试市场分析

第十九章东亚热原测试市场分析

第二十章 大洋洲热原测试市场分析

第21章中东和非洲热原测试市场分析

第 22 章 2024-2031 年各国热原测试市场分析

  • 介绍
  • 美国热原测试市场分析
  • 加拿大热原测试市场分析
  • 墨西哥热原测试市场分析
  • 巴西热原测试市场分析
  • 德国热原测试市场分析
  • 义大利热原测试市场分析
  • 法国热原测试市场分析
  • 英国热原测试市场分析
  • 西班牙热原测试市场分析
  • 俄罗斯热原测试市场分析
  • 比荷卢热原测试市场分析
  • 中国热原检测市场分析
  • 日本热原测试市场分析
  • 韩国热原测试市场分析
  • 印度热原测试市场分析
  • 泰国热原检测市场分析
  • 澳洲热原测试市场分析
  • 纽西兰热原检测市场分析
  • GCC国家热原测试市场分析
  • 土耳其热原测试市场分析
  • 南非热原测试市场分析
  • 印尼热原测试市场分析
  • 马来西亚热原测试市场分析

第23章市场结构分析

  • 市场分析：依公司层级
  • 主要参与者的市场占有率分析
  • 市场存在分析

第 24 章 竞争分析

  • 比赛仪表板
  • 竞争标桿
  • 竞争对手详情
    • Thermo Fisher Scientific
    • Merck KGaA
    • Lonza
    • MAT-BioTech
    • Promega Corporation
    • GenScript
    • Associates of Cape Cod, Inc.
    • BIOMERIEUX SA
    • Ella A/S
    • Hycult Biotech Inc.
    • Eurofins Biolab Srl
    • Solvias AG
    • Wickham Laboratories Ltd.
    • Sotera Health（Nelson Laboratories, LLC）
    • Charles River Laboratories
    • Creative Biolabs
    • Sanquin Reagents BV
    • Fujifilm Wako Pure Chemical Corporation
    • MAT Research
    • Xiamen Bioendo Technology Co. Ltd.
    • Microcoat Biotechnologie GmbH
    • PerkinElmer Inc.
    • Orchid Scientific &Innovative Pvt Ltd.

第 25 章先决条件和使用的缩写词

第26章研究方法论

简介目录
Product Code: PMRREP4259

Persistence Market Research has recently published an in-depth analysis of the global Pyrogen Testing Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the Pyrogen Testing Market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2024 to 2031.

The global pyrogen testing market reached US$ 2.04 billion in 2024 and is expected to grow at a CAGR of 12.2% over the next decade. Projections suggest that market revenue will soar to US$ 4.56 billion by 2031, indicating significant and positive market expansion.

Key Insights:

  • Pyrogen Testing Market Size (2024) - US$ 2.04 Bn
  • Projected Market Value (2031) - US$ 4.56 Bn
  • Global Market Growth Rate (2024-2031) - 12.2% CAGR

Pyrogen Testing Market - Report Scope:

Pyrogen testing serves as a critical aspect of pharmaceutical and medical device manufacturing, ensuring the safety and efficacy of products by detecting pyrogen contamination. This report explores the diverse applications and technological advancements driving the adoption of pyrogen testing globally.

Several factors drive the growth of the pyrogen testing market. Stringent regulatory requirements, increasing focus on patient safety, and rising incidences of pyrogen contamination incidents propel market expansion. Additionally, advancements in testing methodologies, such as the adoption of in vitro methods and automated systems, enhance testing accuracy and efficiency, further stimulating market growth.

Market Growth Drivers:

The pyrogen testing market benefits from the stringent regulatory landscape governing pharmaceutical and medical device manufacturing, which mandates the testing of products for pyrogen contamination. Additionally, increasing awareness among manufacturers regarding the importance of pyrogen testing in ensuring product safety and compliance drives market demand. Moreover, technological advancements in testing methodologies, such as the introduction of rapid and automated testing systems, streamline testing processes and reduce turnaround time, fostering market growth.

Market Restraints:

Despite growth prospects, challenges exist in the pyrogen testing market. High costs associated with testing procedures and equipment pose barriers to market entry for small and medium-sized enterprises. Furthermore, the complexity of testing methodologies and the need for specialized expertise limit adoption rates, particularly in emerging economies. Moreover, concerns regarding the accuracy and reliability of certain testing methods may impede market growth, necessitating ongoing research and development efforts to address these challenges.

Market Opportunities:

The pyrogen testing market presents significant opportunities for innovation and expansion. Continued research and development aimed at improving testing methodologies, enhancing sensitivity and specificity, and reducing testing costs are key to unlocking new market avenues. Additionally, the integration of advanced technologies such as robotics and artificial intelligence into testing systems can further streamline processes and improve efficiency, driving market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Pyrogen Testing Market?
  • Which industries and applications are driving the demand for Pyrogen Testing?
  • How are technological advancements reshaping the competitive landscape of the Pyrogen Testing Market?
  • Who are the leading players in the global Pyrogen Testing Market?
  • What emerging trends and future prospects are anticipated in the global Pyrogen Testing Market?

Competitive Intelligence and Business Strategy:

In the realm of pyrogen testing devices, manufacturers are strategically focusing on regulatory approvals, product launches, and acquisitions to bolster their market presence. Eurofins' introduction of PFAS Exposure(TM) in January 2022, the first at-home test for measuring PFAS levels, is a notable advancement. Similarly, Associates of Cape Cod, Inc. (ACC) unveiled PyroSmart NextGen(TM) in April 2021, an innovative recombinant LAL reagent for Bacterial Endotoxin Testing (BET). Lonza's October 2020 launch of the Pyro Cell Monocyte Activation Test System provides a comprehensive in-vitro pyrogen testing solution, combining optimized MAT reagents from Sanquin with Lonza's media and accessories. Persistence Market Research diligently tracks such developments in the pyrogen testing sector, offering detailed insights in their comprehensive report.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • MAT-BioTech
  • Promega Corporation
  • GenScript
  • Associates of Cape Cod, Inc.
  • BIOMERIEUX SA
  • Ella A/S
  • Hycult Biotech Inc.
  • Eurofins Biolab Srl
  • Solvias AG
  • Wickham Laboratories Ltd.
  • Sotera Health (Nelson Laboratories, LLC)
  • Charles River Laboratories
  • Creative Biolabs
  • Sanquin Reagents B.V.
  • Fujifilm Wako Pure Chemical Corporation
  • MAT Research
  • Xiamen Bioendo Technology Co. Ltd.
  • Microcoat Biotechnologie GmbH
  • PerkinElmer Inc.
  • Orchid Scientific & Innovative Pvt Ltd.

Pyrogen Testing Market Segmentation

Pyrogen Testing Market by Product & Service:

  • Instruments

Digital Tele Thermometers Equipment

Automated Endotoxin Testing Equipment

Portable Endotoxin Testing Equipment

Microplate Readers

  • Test Kits & Reagents

Recombinant Factor C Assays

Limulus Amebocyte Lysate (LAL) Tests

  • Chromogenic Tests
  • Turbid metric Tests
  • Gel-Clot Tests

Rabbit Pyrogen Tests

Monocyte Activity Assays

  • Consumables
  • Services

Endotoxin Testing Services

Monocyte Activation Testing Services

Pyrogen Testing Market by Source:

  • In-vitro-based Pyrogen Testing

Whole Blood-based Monocytes

Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes

Cell Line-based Monocytes

  • Animal-based Pyrogen Testing

Recombinant Factor (rFC )

Bacterial Endotoxins (BET)

Rabbit Pyrogen Tests

Pyrogen Testing Market by Application:

  • Injectable Therapeutics
  • Vaccines
  • Orally-dosed Pharmaceuticals
  • Biologics
  • Implantable Medical Devices
  • Dialysis Liquids
  • Toxic/immune-modulatory Drugs
  • Blood-based Products

Pyrogen Testing Market by End User:

  • Pharmaceuticals Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Diagnostic Laboratories
  • Clinical Research Organizations (CROs)
  • Clinical Manufacturing Organizations (CMOs)

Pyrogen Testing Market by Region:

  • North America Pyrogen Testing Market
  • Latin America Pyrogen Testing Market
  • Europe Pyrogen Testing Market
  • South Asia Pyrogen Testing Market
  • East Asia Pyrogen Testing Market
  • Oceania Pyrogen Testing Market
  • Middle East & Africa Pyrogen Testing Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions & Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Clinical Trial Analysis
  • 4.2. Unmet Needs
  • 4.3. Regulatory Scenario
  • 4.4. Methods of Pyrogen and Endotoxin Detection
  • 4.5. Estimated number of tests performed

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure
    • 5.1.3. Global Life Science Market Outlook
    • 5.1.4. Global Pyrogen Testing Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Rising incidence of chronic diseases
    • 5.2.3. Increased spending on pyrogen and endotoxin testing
    • 5.2.4. Shift towards in-vitro testing
    • 5.2.5. Adoption of alternative testing methods
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

  • 6.1. Current COVID 19 Statistics and Probable Future Impact
  • 6.2. Current Economic Projection as compared to 2008 Economic analysis
  • 6.3. Impact of COVID-19 on the healthcare industry.
  • 6.4. Impact of COVID-19 on the global Pyrogen Testing market.

7. Global Pyrogen Testing Market Demand, in Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2031

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2031
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Pyrogen Testing Market - Pricing Analysis

  • 8.1. Global Average Pricing Analysis Benchmark
  • 8.2. Price Analysis by Region.
  • 8.3. Pricing Assumptions

9. Global Pyrogen Testing Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Products & Services

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Products & Services, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Products & Services, 2024-2031
    • 10.3.1. Instruments
      • 10.3.1.1. Digital Tele Thermometers Equipment
      • 10.3.1.2. Automated Endotoxin Testing Equipment
      • 10.3.1.3. Portable Endotoxin Testing Equipment
      • 10.3.1.4. Microplate Readers
    • 10.3.2. Test Kits & Reagents
      • 10.3.2.1. Recombinant Factor C Assays
      • 10.3.2.2. Limulus Amebocyte Lysate (LAL) Tests
        • 10.3.2.2.1. Chromogenic Tests
        • 10.3.2.2.2. Turbidimetric Tests
        • 10.3.2.2.3. Gel-Clot Tests
      • 10.3.2.3. Rabbit Pyrogen Tests
      • 10.3.2.4. Monocyte Activity Assay
    • 10.3.3. Consumables
    • 10.3.4. Services
      • 10.3.4.1. Endotoxin Testing Services
      • 10.3.4.2. Monocyte Activation Testing Services
  • 10.4. Market Attractiveness Analysis By Products & Services

11. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Source

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Source, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Source, 2024-2031
    • 11.3.1. In-vitro based
      • 11.3.1.1. Whole Blood Based Monocytes
      • 11.3.1.2. Peripheral Blood Mononuclear Cells (PBMC) based Monocytes
      • 11.3.1.3. Cell Line Based Monocytes
    • 11.3.2. Animal Based
      • 11.3.2.1. Recombinant factor C (rFC)
      • 11.3.2.2. Bacterial Endotoxin (BET)
      • 11.3.2.3. Rabbit Pyrogen Tests
  • 11.4. Market Attractiveness Analysis By Source

12. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Application

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By Source, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
    • 12.3.1. Injectable Therapeutics
    • 12.3.2. Vaccines
    • 12.3.3. Orally Dosed Pharmaceuticals
    • 12.3.4. Biologics
    • 12.3.5. Implantable Medical Devices
    • 12.3.6. Dialysis Liquids
    • 12.3.7. Toxic/immune-modulatory Drugs
    • 12.3.8. Blood-based Product
  • 12.4. Market Attractiveness Analysis By Application

13. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
    • 13.3.1. Pharmaceuticals Companies
    • 13.3.2. Pharmaceuticals Companies
    • 13.3.3. Biotechnology Companies
    • 13.3.4. Medical Device Companies
    • 13.3.5. Diagnostic Laboratories
    • 13.3.6. Clinical Research Organizations(CRO)
    • 13.3.7. Clinical Manufacturing Organizations (CMOs)
  • 13.4. Market Attractiveness Analysis By End User

14. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
  • 14.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2031
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. East Asia
    • 14.3.5. South Asia
    • 14.3.6. Oceania
    • 14.3.7. Middle East and Africa (MEA)
  • 14.4. Market Attractiveness Analysis By Region

15. North America Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. U.S.
      • 15.3.1.2. Canada
    • 15.3.2. By Products & Services
    • 15.3.3. By Source
    • 15.3.4. By Application
    • 15.3.5. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis

16. Latin America Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 16.3.1. By Country
      • 16.3.1.1. Brazil
      • 16.3.1.2. Mexico
      • 16.3.1.3. Rest of Latin America
    • 16.3.2. By Products & Services
    • 16.3.3. By Source
    • 16.3.4. By Application
    • 16.3.5. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis

17. Europe Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 17.3.1. By Country
      • 17.3.1.1. Germany
      • 17.3.1.2. Italy
      • 17.3.1.3. France
      • 17.3.1.4. U.K.
      • 17.3.1.5. Spain
      • 17.3.1.6. BENELUX
      • 17.3.1.7. Russia
      • 17.3.1.8. Rest of Europe
    • 17.3.2. By Products & Services
    • 17.3.3. By Source
    • 17.3.4. By Application
    • 17.3.5. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis

18. South Asia Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Thailand
      • 18.3.1.3. Indonesia
      • 18.3.1.4. Malaysia
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Products & Services
    • 18.3.3. By Source
    • 18.3.4. By Application
    • 18.3.5. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis

19. East Asia Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 19.3.1. By Country
      • 19.3.1.1. China
      • 19.3.1.2. Japan
      • 19.3.1.3. South Korea
    • 19.3.2. By Products & Services
    • 19.3.3. By Source
    • 19.3.4. By Application
    • 19.3.5. By End User
  • 19.4. Market Attractiveness Analysis
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis

20. Oceania Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 20.3.1. By Country
      • 20.3.1.1. Australia
      • 20.3.1.2. New Zealand
    • 20.3.2. By Products & Services
    • 20.3.3. By Source
    • 20.3.4. By Application
    • 20.3.5. By End User
  • 20.4. Market Attractiveness Analysis
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 21.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Turkey
      • 21.3.1.3. Northern Africa
      • 21.3.1.4. South Africa
      • 21.3.1.5. Rest of Middle East and Africa
    • 21.3.2. By Products & Services
    • 21.3.3. By Source
    • 21.3.4. By Application
    • 21.3.5. By End User
  • 21.4. Market Attractiveness Analysis
  • 21.5. Key Market Participants - Intensity Mapping
  • 21.6. Drivers and Restraints - Impact Analysis

22. Country Wise Pyrogen Testing Market Analysis 2024-2031

  • 22.1. Introduction
    • 22.1.1. Market Value Proportion Analysis, By Key Countries
    • 22.1.2. Global Vs. Country Growth Comparison
  • 22.2. U.S. Pyrogen Testing Market Analysis
    • 22.2.1. By Products & Services
    • 22.2.2. By Source
    • 22.2.3. By Application
    • 22.2.4. By End User
  • 22.3. Canada Pyrogen Testing Market Analysis
    • 22.3.1. By Products & Services
    • 22.3.2. By Source
    • 22.3.3. By Application
    • 22.3.4. By End User
  • 22.4. Mexico Pyrogen Testing Market Analysis
    • 22.4.1. By Products & Services
    • 22.4.2. By Source
    • 22.4.3. By Application
    • 22.4.4. By End User
  • 22.5. Brazil Pyrogen Testing Market Analysis
    • 22.5.1. By Products & Services
    • 22.5.2. By Source
    • 22.5.3. By Application
    • 22.5.4. By End User
  • 22.6. Germany Pyrogen Testing Market Analysis
    • 22.6.1. By Products & Services
    • 22.6.2. By Source
    • 22.6.3. By Application
    • 22.6.4. By End User
  • 22.7. Italy Pyrogen Testing Market Analysis
    • 22.7.1. By Products & Services
    • 22.7.2. By Source
    • 22.7.3. By Application
    • 22.7.4. By End User
  • 22.8. France Pyrogen Testing Market Analysis
    • 22.8.1. By Products & Services
    • 22.8.2. By Source
    • 22.8.3. By Application
    • 22.8.4. By End User
  • 22.9. U.K. Pyrogen Testing Market Analysis
    • 22.9.1. By Products & Services
    • 22.9.2. By Source
    • 22.9.3. By Application
    • 22.9.4. By End User
  • 22.10. Spain Pyrogen Testing Market Analysis
    • 22.10.1. By Products & Services
    • 22.10.2. By Source
    • 22.10.3. By Application
    • 22.10.4. By End User
  • 22.11. Russia Pyrogen Testing Market Analysis
    • 22.11.1. By Products & Services
    • 22.11.2. By Source
    • 22.11.3. By Application
    • 22.11.4. By End User
  • 22.12. BENELUX Pyrogen Testing Market Analysis
    • 22.12.1. By Products & Services
    • 22.12.2. By Source
    • 22.12.3. By Application
    • 22.12.4. By End User
  • 22.13. China Pyrogen Testing Market Analysis
    • 22.13.1. By Products & Services
    • 22.13.2. By Source
    • 22.13.3. By Application
    • 22.13.4. By End User
  • 22.14. Japan Pyrogen Testing Market Analysis
    • 22.14.1. By Products & Services
    • 22.14.2. By Source
    • 22.14.3. By Application
    • 22.14.4. By End User
  • 22.15. South Korea Pyrogen Testing Market Analysis
    • 22.15.1. By Products & Services
    • 22.15.2. By Source
    • 22.15.3. By Application
    • 22.15.4. By End User
  • 22.16. India Pyrogen Testing Market Analysis
    • 22.16.1. By Products & Services
    • 22.16.2. By Source
    • 22.16.3. By Application
    • 22.16.4. By End User
  • 22.17. Thailand Pyrogen Testing Market Analysis
    • 22.17.1. By Products & Services
    • 22.17.2. By Source
    • 22.17.3. By Application
  • 22.18. Australia Pyrogen Testing Market Analysis
    • 22.18.1. By Products & Services
    • 22.18.2. By Source
    • 22.18.3. By Application
    • 22.18.4. By End User
  • 22.19. New Zealand Pyrogen Testing Market Analysis
    • 22.19.1. By Products & Services
    • 22.19.2. By Source
    • 22.19.3. By Application
    • 22.19.4. By End User
  • 22.20. GCC Countries Pyrogen Testing Market Analysis
    • 22.20.1. By Products & Services
    • 22.20.2. By Source
    • 22.20.3. By Application
    • 22.20.4. By End User
  • 22.21. Turkey Pyrogen Testing Market Analysis
    • 22.21.1. By Products & Services
    • 22.21.2. By Source
    • 22.21.3. By Application
    • 22.21.4. By End User
  • 22.22. South Africa Pyrogen Testing Market Analysis
    • 22.22.1. By Products & Services
    • 22.22.2. By Source
    • 22.22.3. By Application
    • 22.22.4. By End User
  • 22.23. Indonesia Pyrogen Testing Market Analysis
    • 22.23.1. By Products & Services
    • 22.23.2. By Source
    • 22.23.3. By Application
    • 22.23.4. By End User
  • 22.24. Malaysia Pyrogen Testing Market Analysis
    • 22.24.1. By Products & Services
    • 22.24.2. By Source
    • 22.24.3. By Application
    • 22.24.4. By End User

23. Market Structure Analysis

  • 23.1. Market Analysis by Tier of Companies
  • 23.2. Market Share Analysis of Top Players
  • 23.3. Market Presence Analysis

24. Competition Analysis

  • 24.1. Competition Dashboard
  • 24.2. Competition Benchmarking
  • 24.3. Competition Deep Dive
    • 24.3.1. Thermo Fisher Scientific
      • 24.3.1.1. Overview
      • 24.3.1.2. Product Portfolio
      • 24.3.1.3. Key Financials
      • 24.3.1.4. SWOT Analysis
      • 24.3.1.5. Strategy Overview
        • 24.3.1.5.1. Marketing Strategy
        • 24.3.1.5.2. Channel Strategy
        • 24.3.1.5.3. Product Strategy
    • 24.3.2. Merck KGaA
      • 24.3.2.1. Overview
      • 24.3.2.2. Product Portfolio
      • 24.3.2.3. Key Financials
      • 24.3.2.4. SWOT Analysis
      • 24.3.2.5. Strategy Overview
        • 24.3.2.5.1. Marketing Strategy
        • 24.3.2.5.2. Channel Strategy
        • 24.3.2.5.3. Product Strategy
    • 24.3.3. Lonza
      • 24.3.3.1. Overview
      • 24.3.3.2. Product Portfolio
      • 24.3.3.3. Key Financials
      • 24.3.3.4. SWOT Analysis
      • 24.3.3.5. Strategy Overview
        • 24.3.3.5.1. Marketing Strategy
        • 24.3.3.5.2. Channel Strategy
        • 24.3.3.5.3. Product Strategy
    • 24.3.4. MAT-BioTech
      • 24.3.4.1. Overview
      • 24.3.4.2. Product Portfolio
      • 24.3.4.3. Key Financials
      • 24.3.4.4. SWOT Analysis
      • 24.3.4.5. Strategy Overview
        • 24.3.4.5.1. Marketing Strategy
        • 24.3.4.5.2. Channel Strategy
        • 24.3.4.5.3. Product Strategy
    • 24.3.5. Promega Corporation
      • 24.3.5.1. Overview
      • 24.3.5.2. Product Portfolio
      • 24.3.5.3. Key Financials
      • 24.3.5.4. SWOT Analysis
      • 24.3.5.5. Strategy Overview
        • 24.3.5.5.1. Marketing Strategy
        • 24.3.5.5.2. Channel Strategy
        • 24.3.5.5.3. Product Strategy
    • 24.3.6. GenScript
      • 24.3.6.1. Overview
      • 24.3.6.2. Product Portfolio
      • 24.3.6.3. Key Financials
      • 24.3.6.4. SWOT Analysis
      • 24.3.6.5. Strategy Overview
        • 24.3.6.5.1. Marketing Strategy
        • 24.3.6.5.2. Channel Strategy
        • 24.3.6.5.3. Product Strategy
    • 24.3.7. Associates of Cape Cod, Inc.
      • 24.3.7.1. Overview
      • 24.3.7.2. Product Portfolio
      • 24.3.7.3. Key Financials
      • 24.3.7.4. SWOT Analysis
      • 24.3.7.5. Strategy Overview
        • 24.3.7.5.1. Marketing Strategy
        • 24.3.7.5.2. Channel Strategy
        • 24.3.7.5.3. Product Strategy
    • 24.3.8. BIOMERIEUX SA
      • 24.3.8.1. Overview
      • 24.3.8.2. Product Portfolio
      • 24.3.8.3. Key Financials
      • 24.3.8.4. SWOT Analysis
      • 24.3.8.5. Strategy Overview
        • 24.3.8.5.1. Marketing Strategy
        • 24.3.8.5.2. Channel Strategy
        • 24.3.8.5.3. Product Strategy
    • 24.3.9. Ella A/S
      • 24.3.9.1. Overview
      • 24.3.9.2. Product Portfolio
      • 24.3.9.3. Key Financials
      • 24.3.9.4. SWOT Analysis
      • 24.3.9.5. Strategy Overview
        • 24.3.9.5.1. Marketing Strategy
        • 24.3.9.5.2. Channel Strategy
        • 24.3.9.5.3. Product Strategy
    • 24.3.10. Hycult Biotech Inc.
      • 24.3.10.1. Overview
      • 24.3.10.2. Product Portfolio
      • 24.3.10.3. Key Financials
      • 24.3.10.4. SWOT Analysis
      • 24.3.10.5. Strategy Overview
        • 24.3.10.5.1. Marketing Strategy
        • 24.3.10.5.2. Channel Strategy
        • 24.3.10.5.3. Product Strategy
    • 24.3.11. Eurofins Biolab Srl
      • 24.3.11.1. Overview
      • 24.3.11.2. Product Portfolio
      • 24.3.11.3. Key Financials
      • 24.3.11.4. SWOT Analysis
      • 24.3.11.5. Strategy Overview
        • 24.3.11.5.1. Marketing Strategy
        • 24.3.11.5.2. Channel Strategy
        • 24.3.11.5.3. Product Strategy
    • 24.3.12. Solvias AG
      • 24.3.12.1. Overview
      • 24.3.12.2. Product Portfolio
      • 24.3.12.3. Key Financials
      • 24.3.12.4. SWOT Analysis
      • 24.3.12.5. Strategy Overview
        • 24.3.12.5.1. Marketing Strategy
        • 24.3.12.5.2. Channel Strategy
        • 24.3.12.5.3. Product Strategy
    • 24.3.13. Wickham Laboratories Ltd.
      • 24.3.13.1. Overview
      • 24.3.13.2. Product Portfolio
      • 24.3.13.3. Key Financials
      • 24.3.13.4. SWOT Analysis
      • 24.3.13.5. Strategy Overview
        • 24.3.13.5.1. Marketing Strategy
        • 24.3.13.5.2. Channel Strategy
        • 24.3.13.5.3. Product Strategy
    • 24.3.14. Sotera Health (Nelson Laboratories, LLC)
      • 24.3.14.1. Overview
      • 24.3.14.2. Product Portfolio
      • 24.3.14.3. Key Financials
      • 24.3.14.4. SWOT Analysis
      • 24.3.14.5. Strategy Overview
        • 24.3.14.5.1. Marketing Strategy
        • 24.3.14.5.2. Channel Strategy
        • 24.3.14.5.3. Product Strategy
    • 24.3.15. Charles River Laboratories
      • 24.3.15.1. Overview
      • 24.3.15.2. Product Portfolio
      • 24.3.15.3. Key Financials
      • 24.3.15.4. SWOT Analysis
      • 24.3.15.5. Strategy Overview
        • 24.3.15.5.1. Marketing Strategy
        • 24.3.15.5.2. Channel Strategy
        • 24.3.15.5.3. Product Strategy
    • 24.3.16. Creative Biolabs
      • 24.3.16.1. Overview
      • 24.3.16.2. Product Portfolio
      • 24.3.16.3. Key Financials
      • 24.3.16.4. SWOT Analysis
      • 24.3.16.5. Strategy Overview
        • 24.3.16.5.1. Marketing Strategy
        • 24.3.16.5.2. Channel Strategy
        • 24.3.16.5.3. Product Strategy
    • 24.3.17. Sanquin Reagents B.V.
      • 24.3.17.1. Overview
      • 24.3.17.2. Product Portfolio
      • 24.3.17.3. Key Financials
      • 24.3.17.4. SWOT Analysis
      • 24.3.17.5. Strategy Overview
        • 24.3.17.5.1. Marketing Strategy
        • 24.3.17.5.2. Channel Strategy
        • 24.3.17.5.3. Product Strategy
    • 24.3.18. Fujifilm Wako Pure Chemical Corporation
      • 24.3.18.1. Overview
      • 24.3.18.2. Product Portfolio
      • 24.3.18.3. Key Financials
      • 24.3.18.4. SWOT Analysis
      • 24.3.18.5. Strategy Overview
        • 24.3.18.5.1. Marketing Strategy
        • 24.3.18.5.2. Channel Strategy
        • 24.3.18.5.3. Product Strategy
    • 24.3.19. MAT Research
      • 24.3.19.1. Overview
      • 24.3.19.2. Product Portfolio
      • 24.3.19.3. Key Financials
      • 24.3.19.4. SWOT Analysis
      • 24.3.19.5. Strategy Overview
        • 24.3.19.5.1. Marketing Strategy
        • 24.3.19.5.2. Channel Strategy
        • 24.3.19.5.3. Product Strategy
    • 24.3.20. Xiamen Bioendo Technology Co. Ltd.
      • 24.3.20.1. Overview
      • 24.3.20.2. Product Portfolio
      • 24.3.20.3. Key Financials
      • 24.3.20.4. SWOT Analysis
      • 24.3.20.5. Strategy Overview
        • 24.3.20.5.1. Marketing Strategy
        • 24.3.20.5.2. Channel Strategy
        • 24.3.20.5.3. Product Strategy
    • 24.3.21. Microcoat Biotechnologie GmbH
      • 24.3.21.1. Overview
      • 24.3.21.2. Product Portfolio
      • 24.3.21.3. Key Financials
      • 24.3.21.4. SWOT Analysis
      • 24.3.21.5. Strategy Overview
        • 24.3.21.5.1. Marketing Strategy
        • 24.3.21.5.2. Channel Strategy
        • 24.3.21.5.3. Product Strategy
    • 24.3.22. PerkinElmer Inc.
      • 24.3.22.1. Overview
      • 24.3.22.2. Product Portfolio
      • 24.3.22.3. Key Financials
      • 24.3.22.4. SWOT Analysis
      • 24.3.22.5. Strategy Overview
        • 24.3.22.5.1. Marketing Strategy
        • 24.3.22.5.2. Channel Strategy
        • 24.3.22.5.3. Product Strategy
    • 24.3.23. Orchid Scientific & Innovative Pvt Ltd.
      • 24.3.23.1. Overview
      • 24.3.23.2. Product Portfolio
      • 24.3.23.3. Key Financials
      • 24.3.23.4. SWOT Analysis
      • 24.3.23.5. Strategy Overview
        • 24.3.23.5.1. Marketing Strategy
        • 24.3.23.5.2. Channel Strategy
        • 24.3.23.5.3. Product Strategy

25. Assumptions and Acronyms Used

26. Research Methodology